June 17, 2024

Abe Ceesay is today’s guest on The Long Run. He’s the CEO of Boston-based Rapport Therapeutics. Rapport started with a $100 million Series A financing in March 2023 from Third Rock Ventures, Arch Venture Partners and Johnson & Johnson Innovation. As the company name subtly suggests, it’s based on biology of R A Ps, or receptor-associated proteins. The idea is... Read More